Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 7/20 | 0.36 |
| ▸ | CNR2 | P34972 | 7/20 | 0.36 |
| ▸ | TACR3 | P29371 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 6/20 | 0.36 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24251486 | 0.93 | CNR1 (0.34) | IMPDH2CNR1CNR2RIPK1LMNA | |
| SCHEMBL24251433 | 0.90 | HSD17B2 (0.34) | LMNAMAPTTHRBALDH1A1 | |
| SCHEMBL24251424 | 0.90 | IMPDH2 (0.42) | IMPDH2CNR1CNR2EGLN1RIPK1 | |
| SCHEMBL24251480 | 0.86 | MAPT (0.35) | LMNAMAPTTHRBALDH1A1 | |
| SCHEMBL24251412 | 0.82 | MEN1 (0.46) | CNR1CNR2LMNAMAPTALDH1A1 | |
| SCHEMBL23355438 | 0.82 | PDE4B (0.35) | MAPTALDH1A1 | |
| SCHEMBL24251581 | 0.81 | LMNA (0.33) | LMNAMAPTTHRB | |
| SCHEMBL24251405 | 0.80 | ROCK2 (0.35) | RIPK1PPARGLMNAMAPTALDH1A1 | |
| SCHEMBL23355480 | 0.79 | KMT2A (0.37) | MAPTALDH1A1 | |
| SCHEMBL24251582 | 0.79 | PPARG (0.46) | TACR3PPARGLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | SDHA, PAH, PIGS | IMPDH2 1231/4885CNR1 904/4885CNR2 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.